Mycophenolate mofetil treatment in conditions different from organ transplantation
- 7 November 2002
- journal article
- review article
- Published by Elsevier in Transplantation Proceedings
- Vol. 34 (7), 2523-2526
- https://doi.org/10.1016/s0041-1345(02)03473-5
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- Combined mycophenolate mofetil and cyclosporin therapy for severe recalcitrant psoriasisClinical and Experimental Dermatology, 2001
- Mycophenolate mofetil as a systemic antipsoriatic agent: positive experience in 11 patientsBritish Journal of Dermatology, 2001
- Change of treatment from cyclosporin to mycophenolate mofetil in severe psoriasisBritish Journal of Dermatology, 2000
- Mycophenolate mofetil and its mechanisms of actionImmunopharmacology, 2000
- Pemphigus foliaceus successfully treated with mycophenolate mofetil as a steroid-sparing agentJournal of the American Academy of Dermatology, 2000
- Mycophenolate mofetil: A new therapeutic option in the treatment of blistering autoimmune diseasesJournal of the American Academy of Dermatology, 1999
- Mycophenolate mofetil in autoimmune and inflammatory skin disordersJournal of the American Academy of Dermatology, 1999
- Mycophenolate Is Effective in the Treatment of Pemphigus VulgarisArchives of Dermatology, 1999
- Psoriasis vulgaris treated successfully with mycophenolate mofetilBritish Journal of Dermatology, 1998
- Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejectionThe Lancet, 1995